ArticleCureus2026

Metabolic Benefits of Saroglitazar 4 mg in Type 2 Diabetes Mellitus With Dyslipidemia: A Retrospective Real-World Observational Cohort Study From India.

Aravinda Jagadeesha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.